Navigation Links
Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention

BEVERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek Pharmaceuticals Corporation announced today the presentation of positive Phase 2 clinical data demonstrating the safety of INO-1001 as well as the potential for INO-1001 as a preventative agent for cardiac reperfusion injury. The study was conducted in subjects with acute ST-elevated myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. The presentation was made in a poster session at the American College of Cardiology (ACC) 56th Annual Scientific Session in New Orleans, Louisiana. INO-1001 is an inhibitor of poly(ADP-Ribose) polymerase (PARP), a nuclear enzyme that directs the repair of damaged DNA via the activation and recruitment of DNA repair enzymes and is being studied as a treatment for certain acute cardiovascular conditions and cancer. Additionally, PARP inhibition shows promise in inflammatory disorders. PARP's role in the inflammatory response may result from its ability to potentiate the activity of key inflammatory transcription factors (NF-kappaB and AP-1).

"Whereas advances in pharmacologic and mechanical reperfusion therapy have improved the outcomes of patients with STEMI, reperfusion injury, which is associated with severe damage to the cardiac tissue, is a significant complication that has no current safe and effective treatment options," commented Dr. Andrew Salzman, Inotek's President and CEO. "These Phase 2 data provide further support for our PARP inhibitor program in cardiovascular disease. These results combined with existing preclinical data suggest that INO-1001 produces significant PARP inhibition and has the potential to protect cardiac tissue from damage."

Researchers from the Brigham and Women's TIMI Study Group and Inotek Pharmaceuticals reported that plasma from patients treated with INO-1001 suppressed ex vivo PARP activation. This effect was observed up to 24 hours following drug admi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inotek Pharmaceuticals Announces Publication of Animal Data from Study of PARP Inhibition as Potential Preventative of Brain Injury Following Stroke
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:3/2/2015)... 2, 2015  Kush Bottles, North ... solutions for the marijuana industry, announced today that ... been nominated for a 2015 Excellence in Entrepreneurship ... Award is designed to recognize individuals who exemplify ... their creativity and determination, have established and nurtured ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical Systems ... it has signed an exclusive distribution agreement with ... flagship product, the Flight 60 mechanical ventilator. The ... providing dependable and affordable mobility. Starting in the ... be sold in the United States ...
(Date:3/2/2015)... , March 2, 2015 Every ... population with nearly 38,000 of those ending ... Aureus), a highly contagious disease, infects approximately ... Each of these and more, not listed, ... casual contact with other infectious individuals, contact ...
Breaking Medicine Technology:Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 2Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 3
... 2011 IBM (NYSE: IBM ) and ... NCD Challenge , a competition among a number ... of students to find new ways to address the rise ... (Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO ) Illnesses such ...
... bio-pharmaceutical companies lose the ability to communicate externally because ... internal Advocacy groups will become more important to a ... cost effectiveness of care by communicating concepts and arranging ... Since internal Advocacy groups are not known ...
Cached Medicine Technology:IBM Launches University Competition to Combat Growth of Non-Communicable Diseases 2IBM Launches University Competition to Combat Growth of Non-Communicable Diseases 3Pharmaceutical Advocacy Groups Focus on Value-of-Care Initiatives 2
(Date:3/2/2015)... 02, 2015 Getting customers to discover ... the goal this March as the 31st annual Frozen ... the National Frozen & Refrigerated Foods Association (NFRA) to ... offers more than 20 delicious frozen selections and is ... The tasty frozen options are crafted with simple ingredients, ...
(Date:3/2/2015)... Today the Brain Injury Association of America (BIAA) officially ... and support the more than 5.3 million Americans who are ... the nation in observing Brain Injury Awareness Month by conducting ... for the 2015 to 2017 campaign is: Not Alone. ... the general public about the incidence of brain injury and ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Market Publishers ... reports worked out by Global Industry Analysts Inc and ... Equipment: Market Research Report . Through 2018, the global ... 6.04% CAGR. The detailed research report suggests a holistic ... radiation therapy equipment as well as covers the top ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Publisher of Idoll Magazine, a medium for the model ... patrons can find, and buy Mango, Passion Fruit, Pink ... Tuesday, March 3rd, 2015, after 1pm. , At a ... Cosmetics has recently came under fire by announcing the ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
Breaking Medicine News(10 mins):Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3
... is a week since the US Court of Federal Claims, ... children who are faulting childhood vaccines containing thimerosal. Commentators ... able to establish a firm link between the vaccines in ... heard is that of Michelle Cedillos. Her parents, Theresa and ...
... the highest level of health boosting antioxidants which could ... disease to cancer -- shows latest research. ... central and northern Europe and northern Asia. Scientists have ... nutritious than other fruits like apples, strawberries, mangoes or ...
... According to a study in the June issue of ... medication etanercept does not appear to cause more infections ... skin disorder , usually requires long-term therapy, according to ... levels of tumor necrosis factor (TNF) are elevated in ...
... diabetes are still in a high risk category with absolutely ... advances in medical science have reduced cardiovascular diseases to quite ... not seem to apply to women with diabetes. ,The ... dropped dramatically over the last few decades. ,The proportion ...
... of Tennessee researcher has discovered an association between foie ... type of amyloid found in rheumatoid arthritis or tuberculosis. ... University of Tennessee Graduate School of Medicine in Knoxville, ... is the first evidence that a food product can ...
... published in PLoS Medicine shows that men can help ... activity. Serious fractures are common among older people and can ... is already recommended that women should take exercise to ... the bones with age is known as osteoporosis. Women are ...
Cached Medicine News:Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 2Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 3Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 4Health News:Etanercept Reduces Psoriasis 2Health News:Diabetic Womens Death Rate Shows No Decline 2Health News:Scientists Establish Link Between Foie Gras and Disease 2Health News:Exercise Reduces Fracture in Men 2
... Urinalysis WorkCell System - A Single ... per hour, with true load-and-go productivity ... Clinitek Atlas and UF-100 for complete ... systems working together deliver utmost reliability. ...
... one of the 3 major naturally occurring ... In terms of estrogenic activity, estriol is ... is produced almost exclusively during pregnancy, and ... normal human fetus. During pregnancy, the production ...
... of the three major naturally-occurring estrogens. Other ... is produced primarily from androstenedione originating from ... In premenopausal adult women, more than 50% ... In prepubertal children, men and postmenopausal women, ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Medicine Products: